Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1101130 | 0.98 | CYP2D6 (0.33) | HPGDALOX15CHRNB2CHRNB4CHRNA3 | |
| Water SCHEMBL17418171 | 0.98 | HPGD (0.33) | HPGDALOX15CHRNB2CHRNB4CHRNA3 | |
| Bromide SCHEMBL2455526 | 0.98 | SMN1; SMN2 (0.33) | HPGDALOX15CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL12863230 | 0.86 | — | — | |
| SCHEMBL12863227 | 0.82 | TP53 (0.36) | SMN1; SMN2TP53 | |
| SCHEMBL1100784 | 0.79 | CDC25A (0.32) | — | |
| Methoxyacetic Acid SCHEMBL17418246 | 0.79 | PABPC1 (0.35) | USP2PABPC1 | |
| SCHEMBL602904 | 0.77 | — | — | |
| SCHEMBL10257219 | 0.77 | HPGD (0.30) | HPGDALOX15 | |
| Hydrochloric Acid SCHEMBL9784174 | 0.75 | TP53 (0.46) | SMN1; SMN2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3636638-A1 | COMPOSITION COMPRISING AN IONIC LIQUID WITH FLUORINATED ANION | proionic GmbH (AT) | 2020-04-15 | — | — | EP | claimed |
| US-20220190331-A1 | LITHIUM BATTERY AND USE OF A GERMANIUM ORGANYL-BASED ELECTROLYTE ADDITIVE AS AN ELECTROLYTE ADDITIVE THEREIN | BAYERISCHE MOTOREN WERKE AKTIENGESELLSCHAFT (DE) | 2022-06-16 | — | — | US | disclosed |
| US-20220173435-A1 | LITHIUM BATTERY AND USE OF A UREA-BASED ELECTROLYTE ADDITIVE AS AN ELECTROLYTE ADDITIVE THEREIN | BAYERISCHE MOTOREN WERKE AKTIENGESELLSCHAFT (DE) | 2022-06-02 | — | — | US | disclosed |
| US-11286356-B2 | Method for fusing aramid/aramid fibres | PROIONIC GMBH (AT) | 2022-03-29 | — | — | US | disclosed |
| EP-3948998-A1 | LITHIUM BATTERY AND USE OF A GERMANIUM ORGANYL-BASED ELECTROLYTE ADDITIVE AS AN ELECTROLYTE ADDITIVE THEREIN | Bayerische Motoren Werke Aktiengesellschaft (DE) | 2022-02-09 | — | — | EP | disclosed |
| EP-3949000-A1 | LITHIUM BATTERY AND USE OF A UREA-BASED ADDITIVE AS AN ELECTROLYTE ADDITIVE CONTAINED THEREIN | Bayerische Motoren Werke Aktiengesellschaft (DE) | 2022-02-09 | — | — | EP | disclosed |
| EP-3527639-B1 | A METHOD FOR BONDING A THERMOPLASTIC MATERIAL BY MICROWAVE-IRRADIATION | PROIONIC GMBH (AT) | 2021-09-08 | — | — | EP | disclosed |
| WO-2020200399-A1 | LITHIUM BATTERY AND USE OF A GERMANIUM ORGANYL-BASED ELECTROLYTE ADDITIVE AS AN ELECTROLYTE ADDITIVE THEREIN | BAYERISCHE MOTOREN WERKE AKTIENGESELLSCHAFT (DE) | 2020-10-08 | — | — | WO | disclosed |
| WO-2020192927-A1 | LITHIUM BATTERY AND USE OF A UREA-BASED ADDITIVE AS AN ELECTROLYTE ADDITIVE CONTAINED THEREIN | BAYERISCHE MOTOREN WERKE AKTIENGESELLSCHAFT (DE) | 2020-10-01 | — | — | WO | disclosed |
| US-20200270405-A1 | METHOD FOR FUSING ARAMID/ARAMID FIBRES | PROIONIC GMBH (AT) | 2020-08-27 | — | — | US | disclosed |
| US-20110045359-A1 | Reactive ionic liquids | MERCK PATENT GESELLSCHAFT (DE) | 2011-02-24 | — | — | US | disclosed |
| US-7803792-B2 | Quaternary ammonium compounds | ASAHI KASEI PHARMA CORPORATION (JP) | 2010-09-28 | — | — | US | disclosed |
| US-20100099031-A1 | NONAQUEOUS ELECTROLYTES AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERIES EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2010-04-22 | — | — | US | disclosed |
| EP-2166611-A1 | NONAQUEOUS ELECTROLYTE, AND RECHARGEABLE BATTERY WITH THE NONAQUEOUS ELECTROLYTE | Mitsubishi Chemical Corporation (JP) | 2010-03-24 | — | — | EP | disclosed |
| WO-2009132740-A2 | REACTIVE IONIC LIQUIDS | MERCK PATENT GMBH, (DE) | 2009-11-05 | — | — | WO | disclosed |
| US-7312208-B2 | Quaternary ammonium compounds | ASAHI KASEI PHARMA CORPORATION (JP) | 2007-12-25 | — | — | US | disclosed |
| US-20070203115-A1 | Novel quaternary ammonium compounds | ASAHI KASEI PHARMA CORPORATION (JP) | 2007-08-30 | — | — | US | disclosed |
| US-20070190041-A1 | Novel benzothiazepine and bensothiepine compounds | ASHAI KASEI PHARAMA CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
| US-4671855-A | Paper sizing and composition and method | OLIN CORPORATION (US) | 1987-06-09 | — | — | US | disclosed |
| US-4367298-A | CURABLE, COATINGS | SCM CORPORATION (US) | 1983-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070203115-A1 | Novel quaternary ammonium compounds | SLC10A2, SLC10A1, ABCB11 | HPGD 3151/4885ALOX15 3261/4885CHRNB2 2528/4885 |
| US-20110045359-A1 | Reactive ionic liquids | INPPL1, PIK3CG, PTEN | HPGD 4654/4885ALOX15 3843/4885CHRNB2 1870/4885 |
| US-20070190041-A1 | Novel benzothiazepine and bensothiepine compounds | SLC10A1, GOT1, CES1 | HPGD 3807/4885ALOX15 722/4885CHRNB2 4564/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.